Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 result for glasdegib

  1. Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal) (TA646)

    NICE is unable to make a recommendation on glasdegib with chemotherapy for untreated acute myeloid leukaemia because Pfizer did not provide an evidence submission.

    Sections for TA646